SEGUIN, Texas – An infusion center in Seguin that treats COVID-19 patients with monoclonal antibody treatment increases its resources from Tuesday.
According to a press release, the state-supported regional infusion center of Guadalupe Regional Medical Center will increase its capacity from the current 25 to 30 daily infusions of the treatment to 50 patients per day.
Governor Greg Abbott has requested that the Texas Emergency Management Department contract with a private supplier to provide additional equipment and personnel needed for the GRMC infusion center.
The GRMC began administering the monoclonal antibodies on a small scale in December 2020 and moved to an infusion center due to increased demand. It serves residents of Guadalupe, Comal, Wilson, Caldwell and other counties in the region.
Patients must be confirmed positive for COVID-19 and have a referral from a primary care provider to seek treatment. The infusions are for COVID-19 patients who are not yet hospitalized or who are receiving supplemental oxygen. Therapeutic drugs can prevent a patient’s condition from getting worse and requiring hospital treatment. The centers are also helping to increase bed capacity in hospitals so that resources are available for the sickest patients. The state rolled out similar measures in November 2020 in communities across Texas.
The following conditions must be met for a patient to be eligible for the monoclonal antibody drug:
The patient should NOT be hospitalized or require oxygen therapy.
The patient should NOT need an increase in oxygen levels, if used for an underlying condition, due to COVID-19.
Patient MUST be within 10 days of symptom onset.
Patients can contact the infusion center by dialing 830-481-4332. Physicians can contact the infusion center to obtain a referral form by faxing a request to 830-401-8267.
Texans can also call 1-800-742-5990 or Click here to find the nearest infusion center.
The US Department of Health and Human Services maintains national map online which displays the locations that have received shipments of therapeutic monoclonal antibodies in the past few weeks.
For insured patients, an administration fee will be billed to their insurer but there is no cost to the patient for antibody treatment.
The expansion of the infusion center is made possible through partnerships between TDEM, GRMC, the Southwest Texas Regional Advisory Council, the City of Seguin and the County of Guadalupe.
Copyright 2021 by KSAT – All rights reserved.